Prospective Study of Restless Legs Syndrome and Coronary Heart Disease Among Women  by Li, Y. et al.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 2 Abstracts 601fractures will need to be weighed against the ability of the drug to prevent
cardiovascular events.Ischemic Preconditioning for Prevention of Contrast Medium-Induced
Nephropathy: Randomized Pilot RenPro Trial (Renal Protection
Trial)
Er F, Nia AM, Dopp H, et al. Circulation 2012;126:296-303.
Conclusion: In patients at high risk for contrast-induced nephrop-
athy, remote ischemic preconditioning (rIPC) before contrast medium
use prevents acute kidney injury (AKI).
Summary: The main predictor of contrast-induced AKI (CI-AKI) is
a decreased estimated glomerular ﬁltration rate (eGFR) of <60 mL/min/
1.73 m2. The magnitude of decrease in eGFR correlates directly with CI-
AKI (Best PJ et al, J Am Coll Cardiol 2002;39:1113-9; and Rihal CS, Circu-
lation 2002;105:2259-64). There is currently no renal protective medicine
that reliably protects high-risk patients from CI-AKI. The authors sought
to test whether a novel prevention strategy of rIPC might help preserve
kidney function in patients undergoing contrast administration for coronary
angiography. Their study is based on extrapolation from data suggesting
rIPC can prevent renal injury during surgery for abdominal aortic aneurysm
(Ali ZA et al, Circulation 2007;116(suppl):I-98-105). In this study, patients
with impaired renal function, as deﬁned by a serum creatinine >1.4 mg/dL or
an estimated glomerular ﬁltration rate <60 mL/min/1.73 m2, who were
undergoing elective coronary angiography were randomized in a 1:1 ratio to
standard carewith or without ischemic preconditioning (n¼ 50 in each group).
The rIPC was performed with intermittent upper-arm ischemia through four
cycles of 5-minute inﬂation and 5-minute deﬂation of a blood pressure cuff.
According to the Mehran Risk Score, both study groups were at high risk for
developing CI-AKI. An increase in serum creatinine $25% or $0.5 mg/dL
above baseline at 48 hours after contrast medium exposure was the primary
end point of the study. In the study, CI-AKI occurred in 26 patients (26%),
20 (40%) in the control group, and in six (12%) in the rIPC group (odds ratio,
0.21; 95% conﬁdence interval, 0.07-0.57; P ¼ .002). This apparent protective
effect was independent of all other factors such as amount of contrast medium
and patient comorbidities. rIPC also signiﬁcantly decreased the incidence of the
composite cardiovascular end point of death, hospitalization, or hemodialysis.
The number needed to treat with rIPC to prevent one case of CI-AKI was
3.6 (95% conﬁdence interval, 2-9).
Comment: The possible beneﬁcial effects of rIPC in patients with
vascular disease have been a bit of a fringe area of research for a number
of years now. This study seems reasonably well preformed, and no major
adverse events occurred related to rIPC. However, this is a single-center
trial, and despite the dramatic P values, the sample size was rather limited.
The design of the trial is relatively simple, the number of patients potentially
available for further study is large, and the need for improved renal protec-
tion in high-risk patients undergoing contrast studies is obvious. One
certainly cannot ﬁnd fault with the authors’ conclusion that “Our ﬁndings
merit a larger trial to establish the effect of remote ischemic preconditioning
on clinical outcomes.”Prospective Study of Restless Legs Syndrome and Coronary Heart
Disease Among Women
Li Y, Walters AS, Chiuve SE, et al. Circulation 2012;126:1689-94.
Conclusion: Women with restless leg syndrome (RLS) for at least 3
years have an elevated risk of coronary heart disease (CHD).
Summary: Patients with RLS (Willis-Ekbom disease) report periodic
leg movements during sleep that may occur up 200 to 300 times per night.
Such leg movements are associated with sympathetically induced heart rate
increases and elevations in blood pressure (Montplaisir J et al, Move Disord
1997;12:61-5; and Ali NJ et al, Sleep 1991;14:163-5). In addition, patients
with RLS frequently have hypertension, depression, and obesity, all of which
may put them at increased risk of heart disease. RLS patients also report
disturbed or insufﬁcient sleep, which can also increase the risk of heart
disease (Cappuccio FP et al, Eur Heart J 2011;32:1484-92). Patients
with RLS have indeed been associated with an increased risk of CHD.
The ﬁrst report of an association of RLS with CHD was in 2001 in Swedish
men (Ulfberg J et al, Mov Disord 2001;16:1159-63). However, this obser-
vation, although conﬁrmed by other cross-sectional studies, was not
conﬁrmed by prospective evaluation in two additional studies. The prospec-
tive studies, however, did not take into account duration of RLS symptoms.
In the current study, the authors examined whether RLS was associated
with an increased risk of CHD in women who participated in the Nurses’
Health Study and took into account duration of RLS symptoms. There
were 70,977 women (mean age, 67 years) free of CHD and stroke at base-
line (2002) who were monitored until 2008. Physician-diagnosed RLS wasdetermined by questionnaire. CHD was deﬁned as myocardial infarction or
fatal CHD. Women who had RLS at the time of entry into the study (base-
line) had a higher risk of developing CHD (multivariable-adjusted hazard
ratio [HR], 1.46; 95% conﬁdence interval [CI], 0.97-2.18). Risk (HR
[95% CI]) was dependent on duration of symptoms, 0.98 (0.44-2.19) for
women with RLS for <3 years and 1.72 (1.09-2.73) for women with
RLS >3 years (P ¼ .03 for trend). Multivariable-adjusted HRs (95% CI)
of women with RLS for >3 years were 1.08 (1.07-3.01) for nonfatal
myocardial infarction and 1.49 (0.55-4.04) for fatal CHD compared with
women without RLS.
Comment: RLS is common and bothersome. Anecdotally, it is
frequently seen in patients with peripheral arterial disease (PAD). Given
the unquestioned association between CHD and PAD, one wonders if
RLS, if carefully studied in patients with PAD, would be found to also be
statistically associated with PAD, perhaps independent of CHD?Shorter Duration of Femoral-Popliteal Bypass Is Associated With
Decreased Surgical Site Infection and Shorter Hospital Length of Stay
Tze-Woei T, Kalish JA, Hamburg NM, et al. J Am Coll Surg 2012;215:
512-8.
Conclusion: In femoral-popliteal bypass performed with autogenous
vein, longer operations are associated with a higher risk of perioperative
surgical site infections and longer hospital stays.
Summary: Multiple factors inﬂuence the duration of a surgical proce-
dure. Some are patient-speciﬁc, whereas others are surgeon-speciﬁc and
system-speciﬁc. Surgeon-speciﬁc factors may include the choice of surgical
technique, surgical judgment, technical skill, and experience. Patient-
speciﬁc factors include presence of scar tissue or inﬂammation, patient
body habitus and physiologic status, and the physical quality of relevant
tissues or organs used in the reconstruction. The efﬁciency of the operating
room support staff and participation of surgical trainees in procedures are
also system-speciﬁc factors that may inﬂuence the duration of surgery.
The authors’ hypothesized shorter operative durations would be associated
with improved outcomes of femoral-popliteal bypass. They used the Amer-
ican College of Surgeon’s NSQIP Dataset from 2005 to 2009 to identify
patients who underwent a femoral-popliteal bypass as a primary operation
with autogenous vein. Operative duration quartiles (Q) were deﬁned as
Q1, 149 minutes; Q2, 150 to 192 minutes; Q3, 193 to 248 minutes;
and Q4, $249 minutes. Perioperative outcomes analyzed included hospital
length of stay, mortality, cardiopulmonary complications, and surgical site
infection. Patient-speciﬁc and system-speciﬁc variables analyzed included
age, body mass index, smoking, diabetes, end-stage renal disease, indication
for surgery, American Society of Anesthesiologist’s class, type of anesthesia,
intraoperative transfusion, nonoperative time in the operating room, and
participation of a trainee during the procedure. Multivariable regression
was used to adjust for variables. There were 2,644 femoral-popliteal bypass
procedures in this study. Patient mean age was 65.9 years, and 62% were
men. Longer operations were associated with increased perioperative
surgical site infection (Q1, 6.3%; Q2, 9.0%; Q3, 10.1%; Q4, 13.9%;
P < .001). Longer surgical durations were also associated with longer
lengths of stay (5.4 6 6.8, 6.1 6 6.7, 7.0 6 11.3, and 8.1 6 8.0 days,
respectively; P < .001). With multivariable analysis, longer operative dura-
tion remained independently associated with a higher rate of surgical site
infection and longer hospital stays. Risk of surgical site infection increased
by 50% with operative durations of $260 minutes compared with operative
times of 150 minutes.
Comment: The relevance of procedure length on patient outcomes
is controversial. Authors have found both positive correlations with com-
plications with increased procedure length (Cruse PJE et al, Arch Surg
1973;107:206-10). Others have found no association between procedure
length and patient outcomes (Scheer A et al, Dis Colon Rectum 2009;
52:1746-52). Most analyses have been of general or laparoscopic surgical
procedures. The authors here present a relatively unique analysis of surgical
duration on outcomes of vascular surgical procedures that attempted to
control for patient-speciﬁc and system-speciﬁc factors. Their conclusion is
that because they controlled for patient-speciﬁc and system-speciﬁc factors,
the length of time required for femoral-popliteal bypass is at least partly inﬂu-
enced by surgeon-speciﬁc factors such as speciﬁc surgical techniques, surgical
judgment, technical skill, and the overall pace of the operation. There was
no denying that the duration of surgery of femoral-popliteal bypass in
the authors’ data was associated with increased surgical site infection and
hospital length of stay. Therefore, it would appear that system-speciﬁc and
surgeon-speciﬁc factors that lower the duration of femoral-popliteal bypass
are reasonable targets to facilitate quality improvement.
